Company / Shareholders' Equity
TREACE MEDICAL CONCEPTS, INC. Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$112.9M
FY2025
5-year range
$776.0K / $112.9M
FY2021-FY2025
Trend
+86.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 5 years, ranging from $776,000 in FY2022 to $113M in FY2025.
Based on SEC 10-K filings.
$113M in FY2025 with a 3-year CAGR of +425.9%.
Improved from $93M to $113M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +425.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +425.9%, indicating consistent growth.
- In FY2025, shareholders' equity increased 86.5% year-over-year.
- Lowest shareholders' equity in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $112.9M | +86.5% |
| FY2024 | $60.5M | -35.0% |
| FY2023 | $93.1M | +11893.9% |
| FY2022 | $776.0K | -75.5% |
| FY2021 | $3.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026